Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Index by author

01 August 2009; volume 34, issue 2

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ackermann-Liebrich, U.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  2. Adler, D.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.
  3. Aliverti, A.

    1. Aliverti, A., M. Quaranta, and P. M. Calverley. " From the authors: ." European Respiratory Journal 34.2 (2009): 522. Web. 24 Feb. 2021.
  4. Ambrosino, N.

    1. Ambrosino, N., N. Carpenè, and M. Gherardi. "Chronic respiratory care for neuromuscular diseases in adults." European Respiratory Journal 34.2 (2009): 444-451. Web. 24 Feb. 2021.
  5. Annesi-Maesano, I.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  6. Ayres, J. G.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
    2. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.

B

  1. Barbato, A.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  2. Battaile, J. T.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  3. Bertuola, F.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  4. Besozzi, G.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  5. Bevilacqua, N.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  6. Black, P. N.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.
  7. Blanc, F-X.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.
  8. Boersma, W. G.

    1. van der Eerden, M. M., and W. G. Boersma. "Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia." European Respiratory Journal 34.2 (2009): 521. Web. 24 Feb. 2021.
  9. Boonstra, A.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  10. Boscardin, W. J.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.
  11. Bracke, K. R.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  12. Brand, P.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  13. Bridevaux, P-O.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  14. Brusasco, V.

    1. Brusasco, V.. "Statistically significant or clinically useful? From population studies to patient care." European Respiratory Journal 34.2 (2009): 291-292. Web. 24 Feb. 2021.
  15. Brusselle, G. G.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  16. Bush, A.

    1. Bush, A., and C. Hogg. "Many a slip?." European Respiratory Journal 34.2 (2009): 293-294. Web. 24 Feb. 2021.
    2. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

C

  1. Calverley, P. M.

    1. Aliverti, A., M. Quaranta, and P. M. Calverley. " From the authors: ." European Respiratory Journal 34.2 (2009): 522. Web. 24 Feb. 2021.
  2. Carpenè, N.

    1. Ambrosino, N., N. Carpenè, and M. Gherardi. "Chronic respiratory care for neuromuscular diseases in adults." European Respiratory Journal 34.2 (2009): 444-451. Web. 24 Feb. 2021.
  3. Carré, P.

    1. Guilleminault, L., P. Carré, and P. Diot. "Hypersensitivity pneumonitis associated with temozolomide." European Respiratory Journal 34.2 (2009): 526. Web. 24 Feb. 2021.
  4. Centis, R.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  5. Chen, L.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.
  6. Christmas, T.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.
  7. Coirault, C.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.
  8. Colthurst, J. R.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.
  9. Conradi, S. H.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  10. Cooper, C. B.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.
  11. Curjuric, I.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

D

  1. Dales, R.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.
  2. Dawson, A.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.
  3. de Miguel, J.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  4. Demoor, T.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  5. Demoule, A.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.
  6. Deslee, G.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  7. Dey, R.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  8. Dijkmans, B. A. C.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  9. Diot, P.

    1. Guilleminault, L., P. Carré, and P. Diot. "Hypersensitivity pneumonitis associated with temozolomide." European Respiratory Journal 34.2 (2009): 526. Web. 24 Feb. 2021.
  10. Dratva, J.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  11. Drusano, G. L.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.
  12. Duguet, A.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

E

  1. Ebi, K. L.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  2. Ekeowa, U. I.

    1. Gooptu, B., U. I. Ekeowa, and D. A. Lomas. "Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights." European Respiratory Journal 34.2 (2009): 475-488. Web. 24 Feb. 2021.
  3. Eker, B.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  4. El-Chemaly, S.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.
  5. Elewaut, D.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  6. Escarrabill, J.

    1. Escarrabill, J.. "Discharge planning and home care for end-stage COPD patients." European Respiratory Journal 34.2 (2009): 507-512. Web. 24 Feb. 2021.
  7. Esposito, S.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

F

  1. Felber Dietrich, D.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  2. Forastiere, F.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  3. Forsberg, B.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  4. Frescura, A. M.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.
  5. Fueki, M.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  6. Fukuda, T.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

G

  1. Gamble, G. D.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.
  2. Garcia-Pachon, E.

    1. Garcia-Pachon, E.. "Paradoxical movement of the lower ribcage in COPD." European Respiratory Journal 34.2 (2009): 521-522. Web. 24 Feb. 2021.
  3. García de Pedro, J.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  4. Gaspoz, J-M.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  5. Gerbase, M. W.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  6. Gherardi, M.

    1. Ambrosino, N., N. Carpenè, and M. Gherardi. "Chronic respiratory care for neuromuscular diseases in adults." European Respiratory Journal 34.2 (2009): 444-451. Web. 24 Feb. 2021.
  7. Gierada, D. S.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  8. Girardi, E.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  9. Gonzalez-Bermejo, J.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.
  10. Gooptu, B.

    1. Gooptu, B., U. I. Ekeowa, and D. A. Lomas. "Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights." European Respiratory Journal 34.2 (2009): 475-488. Web. 24 Feb. 2021.
  11. Grünberg, K.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  12. Guilleminault, L.

    1. Guilleminault, L., P. Carré, and P. Diot. "Hypersensitivity pneumonitis associated with temozolomide." European Respiratory Journal 34.2 (2009): 526. Web. 24 Feb. 2021.

H

  1. Haas, A. R.

    1. Haas, A. R.. " From the authors: ." European Respiratory Journal 34.2 (2009): 525. Web. 24 Feb. 2021.
  2. Hanna, K.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  3. Hansell, D. M.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.
  4. Harrison, N. K.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.
  5. Harrison, R. M.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.
  6. Heijdra, Y.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  7. Helms, P. J.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  8. Herpich, C. H.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  9. Hill, A. T.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.
  10. Hoffmann, H.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  11. Hogg, C.

    1. Bush, A., and C. Hogg. "Many a slip?." European Respiratory Journal 34.2 (2009): 293-294. Web. 24 Feb. 2021.
  12. Hogg, J. C.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  13. Holtzman, M. J.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  14. Hopkins, R. J.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.
  15. Hurbault, A.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

I

  1. Irving, L. B.

    1. Steinfort, D. P., D. F. Johnson, and L. B. Irving. "Infective complications from endobronchial ultrasound-transbronchial needle aspiration." European Respiratory Journal 34.2 (2009): 524-525. Web. 24 Feb. 2021.

J

  1. Jenkins, G. H.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.
  2. Johnson, D. F.

    1. Steinfort, D. P., D. F. Johnson, and L. B. Irving. "Infective complications from endobronchial ultrasound-transbronchial needle aspiration." European Respiratory Journal 34.2 (2009): 524-525. Web. 24 Feb. 2021.
  3. Jones, R. M.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.
  4. Joos, G. F.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  5. Jorens, P. G.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.

K

  1. Kirsten, D.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  2. Kleerup, E. C.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.
  3. Klein, G.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  4. Korppi, M.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  5. Kotecha, S.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  6. Kuehni, C.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

L

  1. Lange, C.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  2. Lecarpentier, Y.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.
  3. Leone, S.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.
  4. Le Pimpec-Barthes, F.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.
  5. Lewit, R. A.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  6. Liu, L.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.
    2. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  7. Lomas, D. A.

    1. Gooptu, B., U. I. Ekeowa, and D. A. Lomas. "Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights." European Respiratory Journal 34.2 (2009): 475-488. Web. 24 Feb. 2021.
  8. Lucini, V.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

M

  1. Ma, L.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.
  2. MacQuarrie, S.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.
  3. Madsen, F.

    1. Madsen, F.. "Verification of equipment for measuring the diffusion capacity of the lung for carbon monoxide." European Respiratory Journal 34.2 (2009): 523-524. Web. 24 Feb. 2021.
  4. Maes, T.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  5. Martínez-Abad, Y.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  6. Massion, P. P.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.
  7. Medina-Ramón, M.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  8. Metcalf, P.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.
  9. Meyer, T.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  10. Migliori, G. B.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  11. Milne, M.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  12. Mooi, W. J.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  13. Moore, C. M.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  14. Morélot-Panzini, C.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.
  15. Moss, J.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.
  16. Murray, M. P.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.

N

  1. Nicholson, A. G.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

O

  1. O'Callaghan, C.

    1. Thomas, B., A. Rutman, and C. O'Callaghan. "Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia." European Respiratory Journal 34.2 (2009): 401-404. Web. 24 Feb. 2021.
  2. Ocak, S.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.
  3. Okayama, Y.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  4. Okumura, S.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  5. Oliviero, P.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.
  6. Ortmann, J.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  7. Overbeek, M. J.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

P

  1. Pannacci, M.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.
  2. Parizel, P. M.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.
  3. Patterson, A.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  4. Pentland, J. L.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.
  5. Pierce, J.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  6. Pierce, R. A.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.
  7. Pijnenburg, M. W.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  8. Pilette, C.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  9. Postmus, P. E.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  10. Probst-Hensch, N. M.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  11. Puente-Maestu, L.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

Q

  1. Quaranta, M.

    1. Aliverti, A., M. Quaranta, and P. M. Calverley. " From the authors: ." European Respiratory Journal 34.2 (2009): 522. Web. 24 Feb. 2021.

R

  1. Ra, C.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  2. Ratjen, F.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  3. Richardson, M. D.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  4. Rochat, T.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  5. Rutman, A.

    1. Thomas, B., A. Rutman, and C. O'Callaghan. "Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia." European Respiratory Journal 34.2 (2009): 401-404. Web. 24 Feb. 2021.

S

  1. Sagara, H.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  2. Saito, H.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  3. Sanz, M. L.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  4. Sanz, P.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  5. Sasaki, T.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  6. Scaglione, F.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.
  7. Schindler, C.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.
  8. Schulte, M.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  9. Seddon, P.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.
  10. Semple, S.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.
  11. Siafakas, N. M.

    1. Tzortzaki, E. G., and N. M. Siafakas. "A hypothesis for the initiation of COPD." European Respiratory Journal 34.2 (2009): 310-315. Web. 24 Feb. 2021.
  12. Similowski, T.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.
  13. Simonds, A. K.

    1. Simonds, A. K., and D. K. Sokol. "Lives on the line? Ethics and practicalities of duty of care in pandemics and disasters." European Respiratory Journal 34.2 (2009): 303-309. Web. 24 Feb. 2021.
  14. Skrahina, A.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  15. Smit, E. F.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  16. Snoeckx, A.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.
  17. Sokol, D. K.

    1. Simonds, A. K., and D. K. Sokol. "Lives on the line? Ethics and practicalities of duty of care in pandemics and disasters." European Respiratory Journal 34.2 (2009): 303-309. Web. 24 Feb. 2021.
  18. Sos, M. L.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.
  19. Sotgiu, G.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
  20. Steinfort, D. P.

    1. Steinfort, D. P., D. F. Johnson, and L. B. Irving. "Infective complications from endobronchial ultrasound-transbronchial needle aspiration." European Respiratory Journal 34.2 (2009): 524-525. Web. 24 Feb. 2021.
  21. Stockley, R. A.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.
  22. Stringer, W. W.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  23. Stylianou, M. P.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.
  24. Sugiyama, K.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

T

  1. Takeda, K.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  2. Taveira-DaSilva, A.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.
  3. Thomas, B.

    1. Thomas, B., A. Rutman, and C. O'Callaghan. "Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia." European Respiratory Journal 34.2 (2009): 401-404. Web. 24 Feb. 2021.
  4. Thomas, R. K.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.
  5. Turnbull, K.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.
  6. Tzortzaki, E. G.

    1. Tzortzaki, E. G., and N. M. Siafakas. "A hypothesis for the initiation of COPD." European Respiratory Journal 34.2 (2009): 310-315. Web. 24 Feb. 2021.

V

  1. van der Eerden, M. M.

    1. van der Eerden, M. M., and W. G. Boersma. "Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia." European Respiratory Journal 34.2 (2009): 521. Web. 24 Feb. 2021.
  2. Vandooren, B.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.
  3. Van Marck, E.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.
  4. Villar, F.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.
  5. Villeneuve, P. J.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.
  6. Vonk, M. C.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  7. Vonk-Noordegraaf, A.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.
  8. Voskuyl, A. E.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

W

  1. Watanabe, N.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.
  2. Wencker, M.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.
  3. Windt, M.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
  4. Wood, A. M.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.
  5. Woods, J. C.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

Y

  1. Young, R. P.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.
  2. Yuki, K.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

Z

  1. Zellweger, J-P.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
Back to top
PreviousNext
European Respiratory Journal: 34 (2)
  • Table of Contents
  • Index by author

Search Within This Issue

Jump to

  • Editorial
  • ERS Position Statement
  • Perspective
  • Original Articles: Occupational and environmental lung disease
  • Original Articles: COPD and smoking-related disorders
  • Original Articles: α1-Antitrypsin deficiency
  • Original Articles: Cystic fibrosis and non-cystic fibrosis bronchiectasis
  • Original Articles: Critical care and lung injury
  • Original Articles: Lung involvement of systemic disease
  • Original Articles: Thoracic oncology
  • Original Articles: Tuberculosis
  • Original Articles: Respiratory infections
  • Original Articles: Cell and animal studies
  • Scientific Assembly Update
  • Review
  • Series
  • Letter
  • Correspondence
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
  • The effects of coronavirus on human nasal ciliated respiratory epithelium
  • Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
  • Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society